| 2000 |
Crystal structure of yeast eEF1A in complex with the catalytic C-terminus of eEF1Bα (1.67 Å) revealed that eEF1Bα destroys the Mg²⁺ binding site in eEF1A to facilitate GDP/GTP exchange, and that the same domain of eEF1A that interacts with eEF1Bα also binds the CCA-aminoacyl end of tRNA, establishing a competition mechanism between the exchange factor and aminoacyl-tRNA. |
X-ray crystallography (1.67 Å resolution) |
Molecular cell |
High |
11106763
|
| 2001 |
Crystal structures of intermediate nucleotide-exchange states (eEF1A–eEF1Bα–GDP–Mg²⁺, –GDP, and –GDPNP) showed that Mg²⁺ removal is the central catalytic event in nucleotide exchange; mutation of eEF1Bα Lys205, which inserts into the Mg²⁺ binding site, is lethal. |
X-ray crystallography (2.05–3.0 Å) combined with in vivo lethality assay |
Nature structural biology |
High |
11373622
|
| 2002 |
eEF1A is the predominant export substrate of Exportin-5 (Exp5/RanBP21) and is exported from the nucleus via aminoacylated tRNAs; this cargo–exportin interaction is indirect, mediated through the tRNA. Exp5 and other exportins actively exclude eEF1A and other translation factors from the nucleus, suppressing nuclear translation. |
Identification of nuclear export substrate by biochemical fractionation, RanBP21 binding assays, cellular localization |
The EMBO journal |
High |
12426392
|
| 2003 |
TCTP (translationally controlled tumor protein) acts as a guanine nucleotide dissociation inhibitor (GDI) for eEF1A: it preferentially stabilizes the GDP-bound form and impairs the GDP-to-GTP exchange promoted by eEF1Bβ. TCTP interacts with both eEF1Bβ and eEF1A in vitro and in vivo. |
Yeast two-hybrid, in vitro and in vivo binding assays, MS confirmation, GTPase nucleotide exchange assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
14623968
|
| 2002 |
Mammalian eEF1A forms a stable noncanonical ternary complex with GDP and uncharged tRNA (Kd ~20 nM), which then interacts with phenylalanyl-tRNA synthetase (PheRS) to form a quaternary complex (Kd ~9 nM), supporting tRNA channeling during the elongation cycle. |
Gel retardation, surface plasmon resonance (BIAcore), fluorescence binding assay |
European journal of biochemistry |
High |
12354112
|
| 2009 |
The Legionella pneumophila effector SidI specifically interacts with eEF1A and eEF1Bgamma, inhibiting host protein synthesis. SidI mutants that retain target binding but lose toxicity suggest SidI enzymatically modifies eEF1A/eEF1Bgamma. This interaction also leads to eEF1A-mediated activation of HSF1 stress response. |
Yeast lethality screen, co-immunoprecipitation, dominant-negative SidI mutants, HSF1 activation assay |
Cellular microbiology |
High |
19386084
|
| 2012 |
A conserved PUF–Ago–eEF1A complex attenuates translation elongation. FBF-1 (PUF)–CSR-1 (Ago) heterodimer inhibits eEF1A GTPase activity in vitro, and mammalian PUM2–Ago–eEF1A inhibits translation after initiation, causing ribosome accumulation within the ORF near the exit tunnel. |
Co-immunoprecipitation in C. elegans and mammals, recombinant protein in vitro GTPase assay, in vitro translation assay, ribosome profiling |
Nature structural & molecular biology |
High |
22231398
|
| 2014 |
eEF1A1 (but not eEF1A2) participates in the heat shock response by recruiting HSF1 to the HSP70 promoter to activate transcription, then associates with elongating RNA Pol II and the HSP70 mRNA 3'UTR to stabilize the mRNA and facilitate its transport to active ribosomes. eEF1A1-depleted cells show severely impaired HSR and thermotolerance. |
ChIP, RNA immunoprecipitation, live-cell imaging, siRNA knockdown, thermotolerance assay |
eLife |
High |
25233275
|
| 2019 |
METTL13 dimethylates eEF1A at lysine 55 (eEF1AK55me2), increasing eEF1A's intrinsic GTPase activity in vitro and protein production in cells. This modification is upregulated in Ras-driven cancers and METTL13 deletion dramatically reduces neoplastic growth in mouse models and PDX tumors. |
In vitro methyltransferase assay, GTPase assay, ribosome profiling, mouse tumor models, PDX, CRISPR knockout |
Cell |
High |
30612740
|
| 2018 |
Human METTL13 contains two distinct methyltransferase domains: one methylates the eEF1A N-terminus and one methylates Lys55. Structural analysis provides mechanistic insight into N-terminal recognition. Loss of METTL13 alters translation dynamics and codon-specific translation rates as shown by ribosome profiling. |
In vitro methyltransferase assay, X-ray crystallography, ribosome profiling, site-directed mutagenesis |
Nature communications |
High |
30143613
|
| 2014 |
METTL10 (a seven-β-strand methyltransferase) specifically trimethylates human EF1A1 at lysine 318 in mammalian cells; siRNA knockdown of METTL10 decreases EF1A1 K318 methylation levels in vivo. |
ProSeAM chemical probe labeling, quantitative MS proteomics, siRNA knockdown, in vitro methyltransferase assay |
PloS one |
High |
25144183
|
| 2017 |
METTL21B specifically methylates Lys-165 of human eEF1A in an aminoacyl-tRNA- and GTP-dependent manner. This methylation is dynamic, tissue-variable, and inducible by ER stress. Genetic ablation of METTL21B in mammalian cells substantially alters mRNA translation as measured by ribosome profiling. |
In vitro methyltransferase assay, ribosome profiling, cell-based KO, MS site-mapping |
Nucleic acids research |
High |
28108655
|
| 2017 |
A novel 7BS methyltransferase (eEF1A-KMT4) methylates K36 of eEF1A in vitro and in vivo; knockout of EEF1AKMT4 affects translation dynamics and alters codon-specific translation speed as shown by ribosome profiling. |
In vitro enzymology, KO cell lines, ribosome profiling, MS site-mapping |
Nucleic acids research |
High |
28520920
|
| 2010 |
TβR-I (type I TGF-β receptor) phosphorylates eEF1A1 at Ser300 in vitro and in vivo. Ser300 is important for aminoacyl-tRNA binding; phosphorylation or mutation at Ser300 inhibits protein synthesis in vitro and in vivo and correlates with inhibition of cell proliferation. |
In vitro kinase assay, site-directed mutagenesis, in vitro/in vivo translation assay, cell proliferation assay |
Current biology : CB |
High |
20832312
|
| 2008 |
eEF1A plays a role in nuclear protein export in mammalian cells: it interacts specifically with the TD-NEM (transcription-dependent nuclear export motif) of VHL and PABP1, and siRNA knockdown or antibody-mediated depletion of eEF1A prevents nuclear export of TD-NEM-containing proteins. eEF1A acts from the cytoplasmic side of the nuclear envelope without entering the nucleus. |
siRNA knockdown, antibody-mediated depletion, nuclear retention assay, in vitro nuclear export assay, co-IP, point mutations |
Molecular biology of the cell |
High |
18799616
|
| 2021 |
The antiviral drug plitidepsin exerts its anti-SARS-CoV-2 activity through inhibition of eEF1A; a drug-resistant eEF1A mutant was used to confirm that eEF1A is the essential host target mediating antiviral efficacy. |
Drug-resistant mutant generation, in vitro antiviral assay, in vivo mouse models of SARS-CoV-2 |
Science (New York, N.Y.) |
High |
33495306
|
| 2007 |
Crystal structure of the ZPR1 domain tandem shows that ZPR1 binds preferentially to GDP-bound eEF1A but does not directly affect nucleotide exchange kinetics. However, ZPR1 efficiently displaces eEF1Bα from nucleotide-free eEF1A complexes, suggesting a role as a negative regulator of eEF1A activation. Structure-based mutations abolishing eEF1A binding impair cell growth and proliferation. |
X-ray crystallography, nucleotide exchange kinetics assay, competitive displacement assay, structure-guided mutagenesis, cell growth/proliferation assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
17704259
|
| 2008 |
eEF1Bα can disrupt eEF1A-induced actin organization. Mutational analysis shows that eEF1Bα Phe163, which contacts the domain of eEF1A involved in binding actin, aa-tRNA, and eEF1Bα, is critical for nucleotide exchange activity and cell morphology. This reveals that eEF1Bα coordinates eEF1A's dual roles in actin bundling and protein synthesis. |
In vitro actin bundling assay, eEF1Bα site-directed mutagenesis, growth and morphology phenotyping in yeast, nucleotide exchange assay |
The Journal of biological chemistry |
High |
19095653
|
| 2011 |
eEF1A binds the Gcn2 kinase C-terminal domain (CTD) and inhibits Gcn2-mediated phosphorylation of eIF2α (but not Gcn2 autophosphorylation). This interaction is diminished in amino-acid-starved cells and by uncharged tRNA in vitro, implicating eEF1A as an inhibitor of the Gcn2 amino acid sensing pathway. |
Affinity purification (His-eEF1A), co-IP, GST pulldown with purified proteins, in vitro kinase assay |
The Journal of biological chemistry |
High |
21849502
|
| 2011 |
Cytosolic AID in B cells is held in an ~11S complex in good stoichiometry with eEF1A; this interaction depends on the C-terminal domain of eEF1A and is destroyed by AID mutations that affect cytosolic retention. Thus eEF1A functions as a cytosolic retention factor for AID. |
Endogenous tagging (avoiding overexpression), co-IP, domain mapping, AID cytosolic retention mutations |
Proceedings of the National Academy of Sciences of the United States of America |
High |
22042842
|
| 2010 |
eEF1A directly activates sphingosine kinase 1 (SK1); this activation is dependent on the guanine nucleotide state: eEF1A·GDP, but not eEF1A·GTP, activates SK1 in vitro. Elevating eEF1A·GDP levels via the GDI TCTP increases SK1 activity in cells. A truncated eEF1A1 variant (PTI-1) lacking the G-protein domain constitutively activates SK1 and this is required for PTI-1-induced neoplastic transformation. |
In vitro SK1 activity assay with defined nucleotide-bound forms, TCTP overexpression in cells, SK1 inhibitors/dominant-negative SK1 rescue experiment |
Oncogene |
High |
20838377
|
| 2012 |
eEF1A associates with defective ribosomal products (DRiPs) to generate a signal for aggresome formation. Knockdown of eEF1A suppresses aggresome formation independently of translation inhibition, as shown by the Legionella toxin SidI which strongly inhibits translation but has marginal effect on aggresome formation. |
siRNA knockdown, SidI toxin pharmacological dissection, aggresome detection assay |
Journal of cell science |
Medium |
22357952
|
| 2009 |
The SAM domain of tumor suppressor DLC1 interacts with EF1A1 (but not EF1A2). Mutations in a hydrophobic patch (F38, L39, F40) abolish the interaction. DLC1 SAM facilitates EF1A1 distribution to membrane periphery/ruffles upon growth factor stimulation and modulates cell migration in a GAP-independent manner. |
Protein precipitation/MS, co-IP, SAM domain NMR structure, mutagenesis, cell migration assay, subcellular localization |
Journal of cell science |
High |
19158340
|
| 2004 |
eEF1A·GTP binding to the valylated 3'-tRNA-like structure of TYMV viral RNA strongly represses minus-strand synthesis by the viral RdRp; this repression is dependent on aminoacylation of the viral RNA and correlates with eEF1A·GTP binding affinity, suggesting eEF1A coordinates translation vs. replication of the viral genome. |
In vitro RdRp transcription assay with purified components, titration of eEF1A·GTP concentration |
Virology |
High |
15033564
|
| 2010 |
eEF1A1 specifically interacts with Ca²⁺/calmodulin (CaM), whereas eEF1A2 does not. Ca²⁺/CaM interaction interferes with eEF1A1's tRNA-binding and actin-bundling activities in vitro, providing a Ca²⁺-dependent regulatory mechanism specific to the eEF1A1 isoform. |
ELISA-based binding test, in vitro tRNA-binding and actin-bundling assays, molecular dynamics simulation |
BMC structural biology |
Medium |
18221514
|
| 1998 |
Site-directed mutagenesis of the nucleotide specificity sequence NKMD (residues 153–156) of yeast eEF1A demonstrated that this sequence is critical for GTP binding affinity, GTP hydrolysis rate, and translational fidelity; all viable mutants showed 1–2 orders of magnitude increase in GTP Km. |
Site-directed mutagenesis, in vitro poly(U)-directed polyphenylalanine synthesis, GTP hydrolysis assay, misincorporation assay |
The Journal of biological chemistry |
High |
9786872
|
| 2004 |
eEF1A exhibits chaperone-like activity: it promotes full renaturation of phenylalanyl-tRNA synthetase (PheRS) and seryl-tRNA synthetase (SerRS) from denatured states and protects them against dilution-induced denaturation. Both GDP- and GTP-bound forms show similar renaturation activity. |
In vitro renaturation assay with purified eEF1A and aminoacyl-tRNA synthetases, comparison with BSA control |
The international journal of biochemistry & cell biology |
Medium |
15109577
|
| 2022 |
Single-molecule fluorescence imaging and cryo-EM showed that didemnin B and ternatin-4 both bind the same site on eEF1A and trap eEF1A in an intermediate state of aa-tRNA selection, preventing eEF1A release and aa-tRNA accommodation. The two drugs show distinct effects on the dynamics of aa-tRNA selection despite sharing the binding site. |
Single-molecule FRET imaging, cryo-EM, in vitro translation assay |
eLife |
High |
36264623
|
| 2010 |
Narciclasine directly binds to recombinant human eEF1A in a nanomolar range (but not to actin or eEF2), and 5 nM narciclasine impairs eEF1A-related actin bundling activity; eEF1A targeting leads to actin cytoskeleton disorganization with cytokinesis impairment and protein synthesis inhibition. |
Direct binding assay with recombinant human eEF1A, yeast-purified eEF1A, actin bundling assay, molecular docking |
FASEB journal |
Medium |
20643906
|
| 2008 |
BPOZ-2 (a CUL3 E3 ubiquitin ligase adaptor) directly binds eEF1A1 through its ankyrin repeats and both BTB/POZ domains (interacting with domains I and III of eEF1A1), promotes eEF1A1 ubiquitylation and degradation, inhibits GTP binding to eEF1A1, and prevents translation in vitro. |
Yeast two-hybrid, pull-down, co-IP, in vitro translation assay, ubiquitylation assay, GTP binding assay |
Genes to cells |
Medium |
18459963
|
| 2016 |
FAT10 stabilizes eEF1A1 by competing with ubiquitin for binding to the same lysines on eEF1A1; FAT10 overexpression decreases ubiquitin-eEF1A1 complex and increases FAT10-eEF1A1 complex, thereby preventing proteasomal degradation of eEF1A1. |
Co-IP, ubiquitination assay, domain mapping, proliferation assay |
Cancer research |
Medium |
27312528
|
| 2010 |
PKCβI phosphorylates eEF1A2 at Ser53 in the nucleus of insulin-stimulated C2C12 myoblasts; only PKCβI (not other PKC isoforms) co-immunoprecipitates with eEF1A in the nucleus, and the PKCβI–eEF1A2 association is dependent on the phosphorylation status of eEF1A2. |
Nuclear proteomics, LC-MS/MS, co-IP, site-directed mutagenesis of Ser53 |
Molecular & cellular proteomics : MCP |
Medium |
20923971
|
| 2009 |
EF1A1 binds the osteopontin (OPN) 5'-UTR and regulates OPN mRNA stability. EF1A1 binding to the 5'-UTR is actin-dependent: in Hep3B cells EF1A1 is bound to actin and also bound to OPN mRNA; pharmacological manipulation increasing the G:F actin ratio releases EF1A1 from actin and increases OPN mRNA stability. |
RNA-protein binding assay, mRNA stability measurement, actin manipulation, EF1A1 deletion constructs |
Experimental cell research |
Medium |
19026636
|
| 2022 |
tRF-Val (a 3'-tRNA-derived fragment) directly binds EEF1A1, mediates its transport into the nucleus, and promotes its interaction with MDM2, thus inhibiting the p53 pathway to promote gastric cancer progression. |
RNA pull-down, co-IP, subcellular fractionation, siRNA knockdown, in vivo tumor model |
Cell death & disease |
Medium |
35585048
|
| 2017 |
eEF1A1 promotes HCC cell proliferation through the STAT1–cyclin D1 pathway: eEF1A1 overexpression or knockdown alters G1 phase progression by regulating STAT1 activity, which in turn controls cyclin D1 transcription by binding its promoter. |
siRNA knockdown, overexpression, cell cycle analysis, ChIP (STAT1 on cyclin D1 promoter), in vitro and in vivo proliferation assay |
Biochemical and biophysical research communications |
Medium |
29079187
|
| 2017 |
eEF1A1 interacts with SMAD4 and represses SMAD4 transactivation. The small peptide sPEP1 (encoded by HNF4A-AS1) facilitates physical interaction between eEF1A1 and SMAD4, leading to transcriptional upregulation of stem cell genes and promotion of NB stem cell self-renewal. |
Co-IP, rescue experiments with interaction-defective mutants, in vivo tumor model |
Oncogene |
Medium |
35318442
|
| 2017 |
Expanded polyalanine (poly(A)) tracts function as nuclear export signals and interact with eEF1A1; knockdown of eEF1A1 partially corrects the cytoplasmic mislocalization of expanded poly(A) proteins and restores their nuclear function, identifying eEF1A1 as a mediator of poly(A) disease protein mislocalization. |
GST pulldown + MS, siRNA knockdown, subcellular localization assay, rescue experiment |
The Journal of biological chemistry |
Medium |
28246169
|
| 2008 |
eEF1A1 binds the novel muscle protein IGFN1 (which is substantially upregulated during muscle denervation) in vitro; the interaction was identified by yeast two-hybrid in human skeletal muscle cDNA library and confirmed biochemically, suggesting a mechanism for down-regulation of protein synthesis via eEF1A1 during denervation. |
Yeast two-hybrid, in vitro binding confirmation, expression analysis in denervated muscle |
Journal of cellular biochemistry |
Low |
18756455
|
| 2012 |
MLIF (monocyte locomotion inhibitory factor) binds directly to eEF1A1 (identified by biotin-conjugated MLIF pull-down + MS). eEF1A1 is required for MLIF-enhanced eNOS mRNA stabilization and eNOS expression; knockdown of eEF1A1 attenuates MLIF-mediated inhibition of inflammatory adhesion molecules. |
Biotin pulldown + MS, siRNA knockdown, mRNA stability assay, adhesion molecule expression |
Stroke |
Medium |
22829547
|
| 2018 |
eEF1A interacts with HIV-1 reverse transcriptase (RT) through surface-exposed acidic residues in the RT thumb domain alpha-J helix (D250, E297, E298, E300). Mutation E300R significantly impairs eEF1A–RT interaction, delays reverse transcription and viral core uncoating, and strongly inhibits HIV-1 replication in CD4+ T cells without affecting RT catalytic activity or heterodimerization. |
Co-IP/binding assay with RT mutants, in vitro RT activity assay, uncoating assay, HIV-1 replication assay in CD4+ T cells |
mBio |
High |
29588400
|
| 2001 |
Peptide elongation factor eEF1A-1 (but not eEF1A-2) promotes cell death in differentiated myotubes: adenoviral introduction of eEF1A-1 accelerates serum deprivation-induced apoptosis (caspase-3 activation), whereas antisense eEF1A-1 protects myotubes. This establishes an isoform-specific pro-death function for eEF1A-1 in skeletal muscle. |
Adenoviral gene transfer, antisense expression, caspase-3 activation assay, cell death measurement |
The Journal of biological chemistry |
Medium |
11724805
|